Modes of transmission and attack rates of group A Streptococcal infection: a protocol for a systematic review and meta-analysis.
Environmental health
Group A Streptococcus
Public health
Systematic review
Transmission
Journal
Systematic reviews
ISSN: 2046-4053
Titre abrégé: Syst Rev
Pays: England
ID NLM: 101580575
Informations de publication
Date de publication:
31 03 2021
31 03 2021
Historique:
received:
10
09
2020
accepted:
19
03
2021
entrez:
1
4
2021
pubmed:
2
4
2021
medline:
25
6
2021
Statut:
epublish
Résumé
Group A Streptococcus (Strep A) is an important cause of mortality and morbidity globally. This bacterium is responsible for a range of different infections and post-infectious sequelae. Summarising the current knowledge of Strep A transmission to humans will address gaps in the evidence and inform prevention and control strategies. The objective of this study is to evaluate the modes of transmission and attack rates of group A streptococcal infection in human populations. This systematic review protocol was prepared according to the Preferred Reporting Items for Systematic reviews and Meta-analysis Protocols (PRISMA-P) 2015 Statement. Using a comprehensive search strategy to identify any transmission studies that have been published in English since 1980, full-text articles will be identified and considered for inclusion against predefined criteria. We will include all studies reporting on Strep A transmission, who have identified a mode of transmission, and who reported attack rates. Risk of bias will be appraised using an appropriate tool. Our results will be described narratively and where feasible and appropriate, a meta-analysis utilizing the random-effects model will be used to aggregate the incidence proportions (attack rates) for each mode of transmission. In addition, we will also evaluate the emm genotype variants of the M protein causing Strep A infection and the association with transmission routes and attack rates, if any, by setting, socioeconomic background and geographical regions. We anticipate that this review will contribute to elucidating Strep A modes of transmission which in turn, will serve to inform evidence-based strategies including environmental health activities to reduce the transmission of Strep A in populations at risk of severe disease. Systematic review registration: PROSPERO ( CRD42019138472 ).
Sections du résumé
BACKGROUND
Group A Streptococcus (Strep A) is an important cause of mortality and morbidity globally. This bacterium is responsible for a range of different infections and post-infectious sequelae. Summarising the current knowledge of Strep A transmission to humans will address gaps in the evidence and inform prevention and control strategies. The objective of this study is to evaluate the modes of transmission and attack rates of group A streptococcal infection in human populations.
METHODS
This systematic review protocol was prepared according to the Preferred Reporting Items for Systematic reviews and Meta-analysis Protocols (PRISMA-P) 2015 Statement. Using a comprehensive search strategy to identify any transmission studies that have been published in English since 1980, full-text articles will be identified and considered for inclusion against predefined criteria. We will include all studies reporting on Strep A transmission, who have identified a mode of transmission, and who reported attack rates. Risk of bias will be appraised using an appropriate tool. Our results will be described narratively and where feasible and appropriate, a meta-analysis utilizing the random-effects model will be used to aggregate the incidence proportions (attack rates) for each mode of transmission. In addition, we will also evaluate the emm genotype variants of the M protein causing Strep A infection and the association with transmission routes and attack rates, if any, by setting, socioeconomic background and geographical regions.
DISCUSSION
We anticipate that this review will contribute to elucidating Strep A modes of transmission which in turn, will serve to inform evidence-based strategies including environmental health activities to reduce the transmission of Strep A in populations at risk of severe disease.
TRIAL REGISTRATION
Systematic review registration: PROSPERO ( CRD42019138472 ).
Identifiants
pubmed: 33789732
doi: 10.1186/s13643-021-01641-5
pii: 10.1186/s13643-021-01641-5
pmc: PMC8011413
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
90Références
J Food Prot. 2007 Jul;70(7):1752-61
pubmed: 17685355
JAMA. 1997 Jan 1;277(1):38-43
pubmed: 8980208
Lancet. 2018 Jul 14;392(10142):161-174
pubmed: 30025809
PLoS One. 2015 Aug 28;10(8):e0136789
pubmed: 26317533
Arch Public Health. 2014 Nov 10;72(1):39
pubmed: 25810908
Med J Aust. 2016 Sep 5;205(5):201-3
pubmed: 27581260
J Clin Invest. 1972 Nov;51(11):2851-62
pubmed: 5080412
Clin Infect Dis. 2011 Apr 15;52(8):988-94
pubmed: 21460311
Am J Hyg. 1957 Jul;66(1):96-101
pubmed: 13444261
Clin Infect Dis. 2005 Aug 1;41(3):334-42
pubmed: 16007530
Br J Dermatol. 2008 Mar;158(3):442-55
pubmed: 18275522
N Engl J Med. 1947 Dec 25;237(26):988-95
pubmed: 18919226
Theor Biol Med Model. 2019 Sep 10;16(1):14
pubmed: 31500635
N Engl J Med. 2017 Aug 24;377(8):713-722
pubmed: 28834488
Bull Hist Med. 1986 Fall;60(3):321-42
pubmed: 3530356
Am J Hyg. 1957 Jul;66(1):85-95
pubmed: 13444260
N Engl J Med. 1960 Apr 7;262:687-94
pubmed: 14406625
Am J Med. 1948 May;4(5):690-701
pubmed: 18856764
Pediatr Infect Dis J. 2013 Jan;32(1):e26-32
pubmed: 22926211
J Hyg (Lond). 1984 Jun;92(3):345-55
pubmed: 6429238
Am J Med. 1947 Jan;2(1):23-5
pubmed: 20278446
N Engl J Med. 2003 Mar 27;348(13):1256-66
pubmed: 12660390
Clin Microbiol Infect. 2013 May;19(5):E222-9
pubmed: 23464795
Lancet. 2014 Dec 13;384(9960):2132-40
pubmed: 25172376
Circulation. 2009 Mar 24;119(11):1541-51
pubmed: 19246689
Pediatrics. 2004 Nov;114(5):1212-9
pubmed: 15520098
Indoor Air. 2006 Oct;16(5):335-47
pubmed: 16948710
Clin Microbiol Infect. 2003 Jun;9(6):554-9
pubmed: 12848734
PLoS Negl Trop Dis. 2018 Jun 13;12(6):e0006577
pubmed: 29897915
Syst Rev. 2015 Jan 01;4:1
pubmed: 25554246
J Infect Dis. 1948 Jan-Feb;82(1):59-71
pubmed: 18898005
Lancet Infect Dis. 2009 Oct;9(10):611-6
pubmed: 19778763
Trans R Soc Trop Med Hyg. 1970;64(1):138-47
pubmed: 4909853
J Infect Dis. 1948 Jan-Feb;82(1):72-85
pubmed: 18898006
J Hosp Infect. 1995 Jun;30(2):162-4
pubmed: 7673692
J Pediatric Infect Dis Soc. 2014 Dec;3(4):336-42
pubmed: 26625454
Emerg Microbes Infect. 2012 Jul;1(7):e2
pubmed: 26038416
J Hyg (Lond). 1937 Jan;37(1):1-13
pubmed: 20475359
Am Fam Physician. 2007 Mar 15;75(6):859-64
pubmed: 17390597
Euro Surveill. 2017 May 11;22(19):
pubmed: 28537550
Emerg Infect Dis. 2007 Dec;13(12):1852-9
pubmed: 18258035
J Lab Clin Med. 1981 Sep;98(3):326-35
pubmed: 7021717
J Hyg (Lond). 1982 Aug;89(1):9-21
pubmed: 7097006
PLoS One. 2013 Sep 16;8(9):e73851
pubmed: 24066079
PLoS Negl Trop Dis. 2016 Jun 13;10(6):e0004727
pubmed: 27294545
BMJ. 2020 Jan 16;368:l6890
pubmed: 31948937
Lancet Infect Dis. 2005 Nov;5(11):685-94
pubmed: 16253886
J Hyg (Lond). 1971 Sep;69(3):347-53
pubmed: 4937852
J Hosp Infect. 2020 Aug;105(4):752-756
pubmed: 32497649